Thunderbird Partners LLP Acadia Pharmaceuticals Inc Transaction History
Thunderbird Partners LLP
- $390 Million
- Q1 2024
Shares
2 transactions
Others Institutions Holding ACAD
# of Institutions
303Shares Held
158MCall Options Held
1.88MPut Options Held
688K-
Baker Bros. Advisors LP New York, NY42.9MShares$820 Million10.04% of portfolio
-
Rtw Investments, LP New York, NY13.8MShares$265 Million4.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.3MShares$255 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$223 Million0.01% of portfolio
-
State Street Corp Boston, MA6MShares$115 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.1B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...